Skip to content
★ Sign in to follow
Total declarations
56
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (24 ops.)
€8.7M

Latest filing published 14 Sept 2011 for Vertex Pharmaceuticals INC / MA, €301k.

Insider track record

Disclosed buys
0
Disclosed sells
24
Signal history

No signal scores available.

Kenneth S. Boger: trading record in brief

All filings by Kenneth S. Boger on record concern Vertex Pharmaceuticals INC / MA. We count 56 filings; the first trade dates from 2 February 2006 and the latest from 13 September 2011.

Sales make up the whole of the open-market record (24 sales, €8.7M). Other entries cover 6 share grants and 25 option exercises. Since January 2011: no purchases and 16 sales on the market.

Most recently, on 14 September 2011, the filings show an option exercise worth €301k in Vertex Pharmaceuticals INC / MA. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Kenneth S. Boger

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations51 total

25 of 51 declarations